MEITAV INVESTMENT HOUSE LTD - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
MEITAV INVESTMENT HOUSE LTD ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q1 2020$57,000
-46.7%
13,000
-10.3%
0.00%
-50.0%
Q3 2019$107,000
+13.8%
14,5000.0%0.01%
+33.3%
Q2 2019$94,000
-23.6%
14,5000.0%0.01%
-14.3%
Q1 2019$123,000
-55.8%
14,500
-71.0%
0.01%
-58.8%
Q4 2018$278,000
-34.1%
50,000
+2.7%
0.02%
-19.0%
Q3 2018$422,000
+8.8%
48,706
+1.5%
0.02%
+23.5%
Q2 2018$388,000
+57.1%
48,0000.0%0.02%
+30.8%
Q1 2018$247,000
+1.2%
48,0000.0%0.01%
-7.1%
Q4 2017$244,00048,0000.01%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Ibex Investors LLC 1,892,593$15,292,0006.10%
GAGNON SECURITIES LLC 281,080$2,271,0000.36%
DISCIPLINED GROWTH INVESTORS INC /MN 2,029,195$16,396,0000.32%
Annandale Capital, LLC 43,532$352,0000.29%
WOODWARD DIVERSIFIED CAPITAL, LLC 23,000$186,0000.12%
IRONWOOD INVESTMENT MANAGEMENT LLC 20,328$164,0000.10%
Claret Asset Management Corp 54,972$444,0000.09%
Migdal Insurance & Financial Holdings Ltd. 890,339$7,194,0000.08%
Shay Capital LLC 47,800$386,0000.08%
ARS Investment Partners, LLC 77,714$628,0000.08%
View complete list of REDHILL BIOPHARMA LTD shareholders